ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Candel Therapeutics Inc

Candel Therapeutics Inc (CADL)

8.26
0.41
(5.22%)
Closed March 07 4:00PM
8.26
0.00
( 0.00% )
Pre Market: 5:27AM

Candel Therapeutics Inc Financial Summary

The current CADL market cap is 268.25M. The company's latest EPS is USD -1.1682 and P/E is -7.07.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -8.86M-10.32M-7.9M-8.57M-8.76M
Net Income -8.44M-11.1M-8.22M-22.24M-10.65M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 125k125k0
Operating Income -25.73M-34.72M-38.39M
Net Income -36.12M-18.79M-37.94M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)
Total Assets 50.06M41.2M31.22M26.49M21.52M
Total Liabilities 27.04M28.46M25.24M36.46M36.77M
Total Equity 23.02M12.75M5.98M-9.97M-15.26M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 89.21M77.69M41.2M
Total Liabilities 25.07M29.98M28.46M
Total Equity 64.14M47.71M12.75M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)
Operating -26.82M-34.24M-8.44M-14.64M-21.21M
Investing -253k-280k-7k-13k-13k
Financing N/A -121k-1.26M690k2.37M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Operating -22.22M-31.42M-34.24M
Investing -1.84M-1.3M-280k
Financing 71.8M19.97M-121k
Market Cap 268.25M
Price to Earnings Ratio -7.07
Price to Sales Ratio 0
Price to Cash Ratio 7.57
Price to Book Ratio 21.05
Dividend Yield -

Share Statistics

Shares Outstanding 32.48M
Average Volume (1 week) 882.66k
Average Volume (1 Month) 1.4M
52 Week Change 432.90%
52 Week High 14.60
52 Week Low 1.34
Spread (Intraday) 0.4 (4.88%)

Company Info

Company Name Candel Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.candeltx.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock